Page last updated: 2024-10-20

phosphorylcholine and Gastric Diseases

phosphorylcholine has been researched along with Gastric Diseases in 1 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Research Excerpts

ExcerptRelevanceReference
"Perifosine inhibits the growth of gastric cancer cells possibly through inhibition of the Akt/GSK3β/C-MYC signaling pathway-mediated down-regulation of AEG-1 that subsequently down-regulated cyclin D1."1.39AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers. ( Chen, X; Huang, W; Li, P; Liang, S; Liu, D; Ma, Z; Wang, X; Yang, L; Zhai, S, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, W1
Yang, L1
Liang, S1
Liu, D1
Chen, X1
Ma, Z1
Zhai, S1
Li, P1
Wang, X1

Other Studies

1 other study available for phosphorylcholine and Gastric Diseases

ArticleYear
AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers.
    Digestive diseases and sciences, 2013, Volume: 58, Issue:10

    Topics: Adenocarcinoma; Adult; Aged; Cell Adhesion Molecules; Cell Line; Cell Line, Tumor; Cell Proliferatio

2013